Working… Menu
Trial record 1 of 1 for:    NCT03248531
Previous Study | Return to List | Next Study

A Study to Test the Efficacy, Safety and Pharmacokinetics of Bimekizumab in Subjects With Moderate to Severe Hidradenitis Suppurativa.

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT03248531
Recruitment Status : Completed
First Posted : August 14, 2017
Last Update Posted : March 20, 2020
Information provided by (Responsible Party):
UCB Pharma ( UCB Biopharma S.P.R.L. )

No Study Results Posted on for this Study
Recruitment Status : Completed
Actual Primary Completion Date : November 23, 2018
Actual Study Completion Date : February 21, 2019
Certification/Extension First Submitted : November 22, 2019